Meridian Medica

01

Identity

Botanical Profile

Humulus lupulus L. — Strobiles (female flower cones / inflorescences). Native to Europe, western Asia, and North America; cultivated globally for brewing and medicinal use

Strobiles: intensely aromatic with resinous, bitter, herbaceous notes. Fresh: pungent, almost skunky green aroma. Dried: mellower with floral and spicy undertones. Lupulin glands (yellow powder) carry the concentrated aromatic resins. Taste is profoundly bitter.

Species Integrity

Hops are relatively low-risk for species adulteration since the strobiles are morphologically distinctive. Primary quality concerns involve degradation rather than substitution: lupulin gland content decreases rapidly with age and improper storage, and alpha acids isomerize and oxidize, reducing potency.

02

Compounds

Active Compound Profile

Alpha acids (humulone, cohumulone, adhumulone)

2–15% dry weight (variety-dependent)

Anti-inflammatory via COX-2 and NF-κB inhibition; bitter taste receptor (TAS2R) activation stimulates digestive secretion

Beta acids (lupulone, colupulone)

2–10% dry weight

Antimicrobial (gram-positive bacteria); anti-inflammatory; antioxidant

8-Prenylnaringenin (8-PN)

Trace (0.001–0.01%)

Most potent known phytoestrogen (50x more potent than genistein); ERα and ERβ agonist

Xanthohumol

0.1–1.0% dry weight

Broad anti-cancer activity; Nrf2 activation; NF-κB inhibition; anti-angiogenic

2-Methyl-3-buten-2-ol (from alpha acid degradation)

Formed during storage/aging

Sedative; GABA-A receptor positive allosteric modulator; primary compound responsible for hops sedative activity

Absorption

Heat isomerization: Alpha acids convert to iso-alpha acids when heated, which are more water-soluble, more bioavailable, and have enhanced anti-inflammatory activity

03

Pathways

Mechanism of Action

★★★☆☆ GABA-A Receptor Modulation (Sedative) 2-Methyl-3-buten-2-ol (hop degradation product) acts as a positive allosteric modulator at GABA-A receptors, enhancing inhibitory neurotransmission

★★★☆☆ Estrogen Receptor Modulation (ERα/ERβ) 8-Prenylnaringenin is the most potent known phytoestrogen; agonizes both ERα and ERβ with selectivity toward ERα

★★★☆☆ NF-κB / Inflammatory Cytokine Axis Iso-alpha acids and xanthohumol inhibit NF-κB nuclear translocation and reduce TNF-α, IL-1β, and IL-6 production

★★★☆☆ Nrf2 / Antioxidant Defense Xanthohumol activates Nrf2 pathway, upregulating glutathione synthesis and phase II detoxification enzymes

★★★☆☆ Bitter Taste Receptor (TAS2R) / Digestive Secretion Humulone and lupulone activate bitter taste receptors in the gut, stimulating gastric acid, bile, and pancreatic enzyme secretion

04

Biomarkers

What It Moves in Your Labs

Biomarker	Direction	Target	Mechanism
hs-CRP	↓ Decrease	<1.0 mg/L	Iso-alpha acids and xanthohumol inhibit NF-κB, reducing systemic inflammatory marker production
Cortisol (evening)	↓ Decrease	Appropriate circadian nadir	GABA-A modulation supports normal cortisol circadian rhythm; improved sleep quality normalizes HPA axis
TPO Antibodies	↓ Decrease	<35 IU/mL	Indirect: anti-inflammatory and improved sleep quality reduce autoimmune activation
Estradiol (perimenopausal)	Context-dependent	Symptom-guided	8-PN provides mild estrogenic support; relevant in perimenopausal context; monitor in estrogen-sensitive conditions

05

Extraction

Extraction & Preparation

Tincture (1:5, 60% ethanol): 90%+ all compound classes

Solubility · Poorly water-soluble raw; isomerized forms (iso-alpha acids) are more water-solubleMenstruum · 60% ethanolPlant material · Whole dried strobiles, crumbled (or pelletized hops)Maceration time · 4–6 weeksRatio · 1:5 (dried)

07

Dosing

Dosing Framework

Bedtime sedative: Take 30–60 minutes before desired sleep time. Consistent nightly use for 2–4 weeks produces best results.

Dose 1

Digestive bitter: 10–20 drops tincture before meals

Take in water 15–20 min before meals; bitter taste on tongue is part of the mechanism

Dose 2

Mild anxiolytic: 0.5–1 mL tincture, 2–3x daily

Low enough dose to avoid significant sedation; combine with passionflower for enhanced anxiolytic effect

Dose 3

Sleep support: 2–4 mL tincture at bedtime

Best combined with valerian (1:1 tincture blend); take 30–60 min before bed; allow 2–4 weeks for full effect

08

Synergies

Synergy Partners

★★★☆☆ Valerian (Valeriana officinalis) Valerenic acid (GABA-A partial agonist) + hops 2-methyl-3-buten-2-ol (GABA-A positive allosteric modulator) = synergistic sleep improvement greater than either alone; most studied herbal sleep combination

★★★☆☆ Passionflower (Passiflora incarnata) Chrysin and apigenin provide complementary GABA-A modulation and anxiolytic effects via benzodiazepine-site binding

★★★☆☆ Chamomile (Matricaria chamomilla) Apigenin provides mild GABA-A modulation; complementary anti-anxiety and GI soothing effects

★★★☆☆ Magnesium (glycinate) Magnesium modulates NMDA receptors and enhances GABA activity; synergistic with hops GABA-A effects

★★★☆☆ Lemon Balm (Melissa officinalis) GABA transaminase inhibition (increases GABA levels) complements hops GABA-A modulation (enhances GABA receptor response)

Signature Stack

THE EVENING CALM TRIO
Components: Hops (strobiles) + Valerian (root) + Passionflower (herb) · Multi-pathway convergence: GABA-A positive allosteric modulation (hops) + GABA-A partial agonism (valerian) + GABA-A benzodiazepine-site binding (passionflower) · The Evening Calm Trio addresses insomnia through three distinct GABA-modulating mechanisms, providing broader anxiolytic and sedative coverage than any single component. This stack does not cause dependence or next-day grogginess. · This combination is the Meridian Medica standard for sleep support in Hashimoto's patients, where insomnia and circadian disruption are among the most quality-of-life-impacting symptoms.

09

Safety

Contraindications & Interactions

Minor Estrogenic activity (8-PN) 8-Prenylnaringenin is the most potent known phytoestrogen. Contraindicated in estrogen receptor-positive breast cancer, endometriosis, uterine fibroids, and other estrogen-sensitive conditions.

Avoid Pregnancy / Lactation AHPA Class 2b — not recommended during pregnancy due to estrogenic activity and uterine stimulant potential. Insufficient lactation safety data.

Minor Depression Hops may exacerbate depression in some individuals due to sedative/CNS depressant effects. Historical eclectic literature warns against use in melancholic depression.

Minor Sedative drug interaction Additive sedation with benzodiazepines, Z-drugs, barbiturates, alcohol, and other CNS depressants. Not dangerous but may cause excessive drowsiness.

Minor Hormonal medications 8-PN may interact with hormonal contraceptives, HRT, and tamoxifen via competitive ER binding.

11

Evidence

Evidence Base

★★★★☆ Sleep Quality (with Valerian) Strong — Multiple RCTs with consistent positive direction

★★★☆☆ Menopausal Symptom Relief Moderate — Small RCTs with positive direction; mechanism well-characterized

★★★☆☆ Anti-Inflammatory (Iso-Alpha Acids) Moderate — Strong in vitro/animal data; limited human clinical data

★★☆☆☆ Digestive Bitter Stimulation Emerging — Traditional use well-documented; modern TAS2R pharmacology supports mechanism

★★☆☆☆ Anxiolytic Effect Emerging — Mechanistically supported; limited dedicated clinical data

Evidence Gaps

The highest-value research gap for Meridian Medica: no published study has evaluated hops-valerian combination specifically in Hashimoto's women with comorbid insomnia, using both sleep quality metrics (PSQI) and thyroid biomarkers (TPO, TSH, FT4) as endpoints. Given that sleep disruption exacerbates autoimmune activation and that many Hashimoto's patients use hops-valerian, this population deserves dedicated study. Additionally, 8-PN's estrogenic effects on thyroid binding globulin (TBG) and thyroid hormone availability warrant characterization in hypothyroid women.

Quality Alert

Hops are relatively low-risk for outright adulteration but quality degradation is the primary concern:

12

Protocol

Protocol Integration

Layer 1: Hypothalamic / Autonomic — HPA axis, circadian rhythm, stress response

Layer 2: Systemic Nutritional Repletion — Micronutrient optimization, antioxidant defense

Layer 3: Gut Permeability / Microbiome — Tight junction repair, motility, SIBO management

Recipe Integration

Evening Calm Tincture (signature preparation)

2–4 mL combined tincture at bedtime

Feed the Markers

Hops appear in the following Meridian Medica protocol contexts: